vs

Side-by-side financial comparison of Dominion Energy (D) and TENET HEALTHCARE CORP (THC). Click either name above to swap in a different company.

TENET HEALTHCARE CORP is the larger business by last-quarter revenue ($5.5B vs $4.2B, roughly 1.3× Dominion Energy). Dominion Energy runs the higher net margin — 13.9% vs 11.7%, a 2.3% gap on every dollar of revenue. On growth, Dominion Energy posted the faster year-over-year revenue change (23.2% vs 9.0%). Over the past eight quarters, Dominion Energy's revenue compounded faster (9.3% CAGR vs 1.5%).

Dominion Energy, Inc., commonly referred to as Dominion, is an American energy company headquartered in Richmond, Virginia that supplies electricity in parts of Virginia, North Carolina, and South Carolina and supplies natural gas to parts of Utah, Idaho and Wyoming, West Virginia, Ohio, Pennsylvania, North Carolina, South Carolina, and Georgia. Dominion also has generation facilities in Indiana, Illinois, Connecticut, and Rhode Island.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

D vs THC — Head-to-Head

Bigger by revenue
THC
THC
1.3× larger
THC
$5.5B
$4.2B
D
Growing faster (revenue YoY)
D
D
+14.2% gap
D
23.2%
9.0%
THC
Higher net margin
D
D
2.3% more per $
D
13.9%
11.7%
THC
Faster 2-yr revenue CAGR
D
D
Annualised
D
9.3%
1.5%
THC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
D
D
THC
THC
Revenue
$4.2B
$5.5B
Net Profit
$586.0M
$644.0M
Gross Margin
Operating Margin
18.0%
15.4%
Net Margin
13.9%
11.7%
Revenue YoY
23.2%
9.0%
Net Profit YoY
871.1%
12.6%
EPS (diluted)
$0.66
$4.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
D
D
THC
THC
Q4 25
$4.2B
$5.5B
Q3 25
$4.5B
$5.3B
Q2 25
$3.7B
$5.3B
Q1 25
$4.1B
$5.2B
Q4 24
$3.4B
$5.1B
Q3 24
$3.8B
$5.1B
Q2 24
$3.5B
$5.1B
Q1 24
$3.5B
$5.4B
Net Profit
D
D
THC
THC
Q4 25
$586.0M
$644.0M
Q3 25
$1.0B
$579.0M
Q2 25
$760.0M
$522.0M
Q1 25
$646.0M
$622.0M
Q4 24
$-76.0M
$572.0M
Q3 24
$954.0M
$681.0M
Q2 24
$572.0M
$477.0M
Q1 24
$674.0M
$2.3B
Operating Margin
D
D
THC
THC
Q4 25
18.0%
15.4%
Q3 25
29.7%
16.8%
Q2 25
29.5%
15.6%
Q1 25
29.9%
18.1%
Q4 24
11.4%
16.2%
Q3 24
32.2%
21.3%
Q2 24
23.3%
14.9%
Q1 24
23.6%
61.2%
Net Margin
D
D
THC
THC
Q4 25
13.9%
11.7%
Q3 25
22.3%
10.9%
Q2 25
20.4%
9.9%
Q1 25
15.8%
11.9%
Q4 24
-2.2%
11.3%
Q3 24
25.2%
13.3%
Q2 24
16.6%
9.3%
Q1 24
19.1%
43.5%
EPS (diluted)
D
D
THC
THC
Q4 25
$0.66
$4.22
Q3 25
$1.16
$3.86
Q2 25
$0.88
$3.14
Q1 25
$0.75
$4.27
Q4 24
$-0.11
$3.79
Q3 24
$1.12
$4.89
Q2 24
$0.65
$2.64
Q1 24
$0.78
$21.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
D
D
THC
THC
Cash + ST InvestmentsLiquidity on hand
$250.0M
$2.9B
Total DebtLower is stronger
$44.1B
$13.1B
Stockholders' EquityBook value
$29.1B
$4.2B
Total Assets
$115.9B
$29.7B
Debt / EquityLower = less leverage
1.52×
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
D
D
THC
THC
Q4 25
$250.0M
$2.9B
Q3 25
$932.0M
$3.0B
Q2 25
$344.0M
$2.6B
Q1 25
$355.0M
$3.0B
Q4 24
$310.0M
$3.0B
Q3 24
$1.8B
$4.1B
Q2 24
$139.0M
$2.9B
Q1 24
$265.0M
$2.5B
Total Debt
D
D
THC
THC
Q4 25
$44.1B
$13.1B
Q3 25
$43.3B
$13.1B
Q2 25
$40.3B
$13.1B
Q1 25
$39.9B
$13.1B
Q4 24
$37.5B
$13.1B
Q3 24
$37.1B
$12.8B
Q2 24
$36.6B
$12.8B
Q1 24
$35.1B
$12.8B
Stockholders' Equity
D
D
THC
THC
Q4 25
$29.1B
$4.2B
Q3 25
$27.7B
$4.0B
Q2 25
$27.2B
$3.7B
Q1 25
$27.4B
$4.2B
Q4 24
$27.3B
$4.2B
Q3 24
$27.5B
$3.8B
Q2 24
$27.1B
$3.5B
Q1 24
$27.4B
$3.5B
Total Assets
D
D
THC
THC
Q4 25
$115.9B
$29.7B
Q3 25
$111.6B
$29.4B
Q2 25
$107.4B
$28.7B
Q1 25
$104.6B
$29.2B
Q4 24
$102.4B
$28.9B
Q3 24
$99.8B
$29.4B
Q2 24
$100.4B
$29.3B
Q1 24
$102.0B
$28.9B
Debt / Equity
D
D
THC
THC
Q4 25
1.52×
3.10×
Q3 25
1.56×
3.26×
Q2 25
1.48×
3.49×
Q1 25
1.46×
3.13×
Q4 24
1.38×
3.14×
Q3 24
1.35×
3.33×
Q2 24
1.35×
3.67×
Q1 24
1.28×
3.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
D
D
THC
THC
Operating Cash FlowLast quarter
$987.0M
$731.0M
Free Cash FlowOCF − Capex
$367.0M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
6.6%
Cash ConversionOCF / Net Profit
1.68×
1.14×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
D
D
THC
THC
Q4 25
$987.0M
$731.0M
Q3 25
$1.9B
$1.1B
Q2 25
$1.2B
$936.0M
Q1 25
$1.2B
$815.0M
Q4 24
$641.0M
$-331.0M
Q3 24
$1.5B
$1.0B
Q2 24
$856.0M
$747.0M
Q1 24
$2.0B
$586.0M
Free Cash Flow
D
D
THC
THC
Q4 25
$367.0M
Q3 25
$778.0M
Q2 25
$743.0M
Q1 25
$642.0M
Q4 24
$-661.0M
Q3 24
$829.0M
Q2 24
$602.0M
Q1 24
$346.0M
FCF Margin
D
D
THC
THC
Q4 25
6.6%
Q3 25
14.7%
Q2 25
14.1%
Q1 25
12.3%
Q4 24
-13.0%
Q3 24
16.2%
Q2 24
11.8%
Q1 24
6.4%
Capex Intensity
D
D
THC
THC
Q4 25
6.6%
Q3 25
5.3%
Q2 25
3.7%
Q1 25
3.3%
Q4 24
6.5%
Q3 24
4.2%
Q2 24
2.8%
Q1 24
4.5%
Cash Conversion
D
D
THC
THC
Q4 25
1.68×
1.14×
Q3 25
1.93×
1.83×
Q2 25
1.64×
1.79×
Q1 25
1.83×
1.31×
Q4 24
-0.58×
Q3 24
1.61×
1.53×
Q2 24
1.50×
1.57×
Q1 24
2.94×
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

D
D

Dominion Energy Virginia$3.0B72%
Nonregulated Electricity Sales$334.0M8%
Contracted Energy$306.0M7%
Other$292.0M7%
Other Nonregulated Revenues$97.0M2%
Other Regulated Revenues$66.0M2%
Alternative Revenue Programs$50.0M1%
Transition Services Agreements$25.0M1%
Regulated Gas Transportation And Storage$10.0M0%
Related Party$5.0M0%

THC
THC

Other$2.9B52%
Health Care Patient Service$1.4B25%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.2B22%
Health Care Other Sources$56.0M1%

Related Comparisons